The pharmaceutical sector, a foundation of the healthcare sector, is undergoing extensive change, essentially caused by lower output of new medicines from research and development (R&D) laboratories, drug pricing pressures, stricter regulatory environments and the overall current economic recession. This sorts strains of all pharmaceutical firms to find better ways to raise their yield of new drugs, complete improvement, to equally treat patients and happen their shareholders assumption.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
